Sepio Capital, LP Novartis Ag Transaction History
Sepio Capital, LP
- $1.03 Billion
- Q4 2024
A detailed history of Sepio Capital, LP transactions in Novartis Ag stock. As of the latest transaction made, Sepio Capital, LP holds 13,668 shares of NVS stock, worth $1.49 Million. This represents 0.13% of its overall portfolio holdings.
Number of Shares
13,668
Previous 13,687
0.14%
Holding current value
$1.49 Million
Previous $1.57 Million
15.5%
% of portfolio
0.13%
Previous 0.15%
Shares
20 transactions
Others Institutions Holding NVS
# of Institutions
1,476Shares Held
134MCall Options Held
1.31MPut Options Held
1.56M-
Dodge & Cox San Francisco, CA12.2MShares$1.33 Billion0.74% of portfolio
-
Primecap Management CO Pasadena, CA11MShares$1.2 Billion0.85% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.18MShares$891 Million0.2% of portfolio
-
Morgan Stanley New York, NY6.87MShares$748 Million0.05% of portfolio
-
Loomis Sayles & CO L P5.58MShares$607 Million0.68% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $234B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...